PBI-Gordon Companies, Inc. Calls on Petspan to Cease and Desist False and Misleading Advertisement, Promotion and Sale of Compounded Rapamycin (Sirolimus) for HCM in Cats

Contributed by: Business Wire

Logo

Tags

Veterinary

Health

Petspan

More Like This

World's First Patent Acquired for Animal Supplement "Pinfenon" (S) (R)

PR Newswire associated0

Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

US FDA grants Priority Review to Sobi's supplemental Biologics Licence Application (sBLA) for Gamifant® (emapalumab-lzsg)

Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress

SIFI Receives COMP Positive Opinion on Orphan Drug Designation for Polihexanide in Treating Fungal Keratitis

PR Newswire associated0

Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus